// App-Quantinova.ai

8 : Safety and Efficacy of New Oral Direct Inhibitors of Thrombin and Factor Xa in Antiphospholipid Syndrome

Researchers

Presenter

  • Nicolas Noel

Principal Investigators

  • Fabien Dutasta

  • Nathalie Costedoat-Chalumeau

  • Patrice Cacoub

  • Jean-Charles Piette

  • David Saadoun

  • Boris Bienvenu

  • Xavier Mariette

  • Loik Geffray

  • Damien Sene

  • Jean-Marie Michot

  • Olivier Fain

  • Luc Darnige

  • Annick Ankri

Medical Centers

  • Medecine interne, CHU Cote de Nacre, CAEN, France

  • Hopital Saint Antoine, DHU iB, Service de Medecine Interne, paris, France

  • Hopital Europeen Georges Pompidou, service -hematologie biologique, Paris, France

  • Rheumatology, Universite Paris-Sud, Le Kremlin Bicetre, France

  • APHP, Hopital Bicetre, Service de Medecine Interne et Immunologie Clinique, Le Kremlin Bicetre, France

  • Groupe Hospitalier Pitie Salpetriere, Service de Medecine Interne, DHU iB, Paris, France

  • Hopital -Instruction des Armees Percy, Service de Medecine Interne, Clamart, France

  • Groupe Hospitalier Pitie Salpetriere, service -hematologie biologique, Paris, France

  • Hopital Lariboisiere, service de Medecine Interne, Paris, France,

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Arrhythmia

  • Venous thrombosis

  • Migraine

  • Lupus

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Fondaparinux sodium

  • rivaroxaban

  • Pradax

  • Evithrom

Outcome

  • N/A

Study Design

  • observational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved